Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Zilver PTX Drug-Eluting Stent regulatory update

December 3, 2012 8:00 AM UTC

FDA approved the Zilver PTX Drug-Eluting Stent from Cook Medical Inc. to treat peripheral artery disease (PAD) in the femoropopliteal artery. The company plans to launch the product in the U.S. early next year. FDA said the drug-eluting stent is the first approved to treat PAD. Cook Medical is part of the Cook Group. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article